Analyst Consensus ?
ConsensusBuy54 ratings
Bullish3564.8%
Neutral1833.3%
Bearish11.9%
Bank of America Corporation · BAC · FY2024 Q3 · Calendar Q4 2024
Bank of America: NII recovery and fee growth support a solid quarter
The supplied analysis supports a constructive but conditional view: improving net interest income, fee growth, and organic customer activity strengthen the earnings trajectory, while rate sensitivity, credit exposure, expenses, and capital rules remain material constraints.
Reported Before market openNYSEFinancial Services
$355.09B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$0.81
Consensus $0.76
EPS surprise
+6.4%
Reported versus consensus
Reported revenue
$25.34B
Consensus $25.25B
Revenue surprise
+0.4%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+0.5%
Event window
SPY move
-0.8%
Same window
Abnormal move
+1.3%
Stock minus SPY
Volume
1.8×
Versus trailing sessions
Subsequent drift
+8.8%
Up to 20 sessions
BACSPY benchmark
Ask FN2 about BAC FY2024 Q3
Transcript, numbers and history already loaded
Why did BAC rise 0.5% after beating EPS estimates in FY2024 Q3?What changed in BAC's guidance and outlook in FY2024 Q3?Give me the bull and bear case for BAC after FY2024 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior quarter, the analysis shifts from an expected NII rebound to reported NII growth, while highlighting stronger checking-account additions, broader digital engagement, and continued fee momentum. The main unresolved issues remain rate sensitivity, deposit costs, commercial credit, expenses, and capital requirements.
Guidance delta
Management guidance sentiment was maintained, with expectations for continued net interest income growth in Q4 and into 2025.
Key takeaways
- The quarter was supported by improving net interest income and fee growth across wealth, investment banking, and global markets.
- Consumer payments, checking-account growth, and digital adoption were identified as important organic-growth drivers.
- Management emphasized disciplined expenses, digital investment, branch expansion, and continued capital returns.
- The central debate remains whether NII growth can continue while rates, deposit costs, and regulation evolve.
Management priorities
- Drive net interest income growth through fixed-rate asset repricing and the deposit base.
- Expand digital capabilities and AI tools while growing consumer and wealth relationships.
- Pursue operating leverage and improved efficiency.
- Continue capital returns while maintaining dividend growth.
- Selectively expand branches in high-growth U.S. markets.
Follow BAC with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$50.92Current
$36Low
$55.97Average
$144High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Oct 15, 2026 |
| Truist Securities | Buy | Buy | Maintain | Oct 15, 2026 |
| TD Cowen | Hold | Hold | Maintain | Oct 15, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 15, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 15, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Oct 15, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Oct 15, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 15, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 15, 2026 |
| Baird | Outperform | Neutral | Upgrade | Oct 15, 2026 |
| UBS | Buy | Buy | Maintain | Oct 5, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 2, 2026 |
| Oppenheimer | Perform | Outperform | Downgrade | Jun 30, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Apr 16, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 16, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Mar 23, 2026 |
| Freedom Broker | Buy | Buy | Maintain | Jan 22, 2026 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jan 7, 2026 |
| HSBC | Hold | Buy | Downgrade | Jul 8, 2025 |
| Argus Research | Buy | Buy | Maintain | Apr 16, 2025 |
| Phillip Securities | Accumulate | Neutral | Upgrade | Oct 18, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Sep 3, 2024 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 18, 2024 |
| CFRA | Sell | Hold | Downgrade | Jul 16, 2024 |
| Seaport Global | Buy | Neutral | Upgrade | Jul 2, 2024 |
| Erste Group | Buy | Hold | Upgrade | Apr 3, 2024 |
| Odeon Capital | Hold | Buy | Downgrade | Jan 16, 2024 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Jan 31, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 19, 2022 |
| Societe Generale | Buy | Hold | Upgrade | Jul 11, 2022 |
| DA Davidson | Neutral | Buy | Downgrade | Jul 9, 2020 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Sep 6, 2019 |
| Raymond James | Market Perform | Outperform | Downgrade | Aug 29, 2019 |
| Nomura | Buy | Buy | Maintain | Oct 16, 2017 |
| Berenberg | Hold | Buy | Downgrade | Apr 24, 2017 |
| Macquarie | Outperform | Neutral | Upgrade | Feb 16, 2017 |
| Standpoint Research | Hold | Buy | Downgrade | Dec 1, 2016 |
| Guggenheim | Neutral | Buy | Downgrade | Nov 15, 2016 |
| Compass Point | Neutral | Neutral | Maintain | Oct 11, 2016 |
| CLSA | Outperform | Outperform | Maintain | Sep 23, 2016 |
| Sandler O'Neill | Buy | Hold | Upgrade | Jan 20, 2016 |
| Bernstein | Outperform | Neutral | Upgrade | Aug 25, 2015 |
| Portales Partners | Sector Perform | Outperform | Downgrade | May 28, 2015 |
| FBR Capital | Outperform | Market Perform | Upgrade | Oct 16, 2014 |
| MKM Partners | Buy | Buy | Maintain | May 21, 2014 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Apr 25, 2014 |
| Scotiabank | Sector Outperform | Sector Perform | Upgrade | Mar 15, 2013 |
| Edward Jones | Buy | Hold | Upgrade | Mar 8, 2013 |
| Rafferty | Buy | Buy | Maintain | Feb 7, 2013 |
| ISI Group | Buy | Buy | Maintain | Jan 7, 2013 |
| Stifel Nicolaus | Buy | Hold | Upgrade | Nov 19, 2012 |
| Stifel | Buy | Hold | Upgrade | Nov 19, 2012 |
| Sterne Agee | Neutral | Neutral | Maintain | Oct 18, 2012 |
| Drexel Hamilton | Buy | Buy | Maintain | Oct 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $50.92. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Analyst unavailable | $64 | $51.39 | +25.7% | Oct 15, 2026 |
| Morgan Stanley | Manan Gosalia | $61 | $51.39 | +19.8% | Oct 15, 2026 |
| Barclays | Analyst unavailable | $68 | $51.39 | +33.5% | Oct 15, 2026 |
| RBC Capital | Gerard Cassidy | $60 | $51.39 | +17.8% | Oct 15, 2026 |
| Redburn Partners | Analyst unavailable | $72 | $54 | +41.4% | Oct 6, 2026 |
| UBS | Analyst unavailable | $67 | $53.75 | +31.6% | Oct 5, 2026 |
| Evercore ISI | Analyst unavailable | $62 | $54.43 | +21.8% | Oct 1, 2026 |
| UBS | Analyst unavailable | $70 | $61.95 | +37.5% | Aug 3, 2026 |
| Truist Financial | Analyst unavailable | $65 | $61.74 | +27.7% | Jul 15, 2026 |
| Argus Research | Stephen Biggar | $70 | $61.79 | +37.5% | Jul 15, 2026 |
| RBC Capital | Analyst unavailable | $65 | $60.62 | +27.7% | Jul 15, 2026 |
| Robert W. Baird | Analyst unavailable | $62 | $60.62 | +21.8% | Jul 15, 2026 |
| Wells Fargo | Analyst unavailable | $69 | $60.62 | +35.5% | Jul 15, 2026 |
| Jefferies | Analyst unavailable | $75 | $60.64 | +47.3% | Jul 14, 2026 |
| UBS | Analyst unavailable | $68 | $60.54 | +33.5% | Jul 7, 2026 |
| Evercore ISI | Analyst unavailable | $63 | $59.63 | +23.7% | Jul 6, 2026 |
| Wells Fargo | Analyst unavailable | $67 | $58.73 | +31.6% | Jul 6, 2026 |
| Morgan Stanley | Manan Gosalia | $67 | $57.96 | +31.6% | Jun 29, 2026 |
| Truist Financial | John McDonald | $64 | $57.66 | +25.7% | Jun 26, 2026 |
| Piper Sandler | Analyst unavailable | $59 | $54.23 | +15.9% | Apr 16, 2026 |
| Truist Financial | Analyst unavailable | $61 | $54.22 | +19.8% | Apr 16, 2026 |
| Oppenheimer | Analyst unavailable | $61 | $54.22 | +19.8% | Apr 16, 2026 |
| Truist Financial | John McDonald | $57 | $48.24 | +11.9% | Mar 26, 2026 |
| Morgan Stanley | Analyst unavailable | $64 | $52.88 | +25.7% | Jan 15, 2026 |
| Evercore ISI | Analyst unavailable | $59 | $52.6 | +15.9% | Jan 15, 2026 |
| Truist Financial | Analyst unavailable | $60 | $52.48 | +17.8% | Jan 15, 2026 |
| HSBC | Saul Martinez | $50 | $55.94 | -1.8% | Jan 7, 2026 |
| Truist Financial | Analyst unavailable | $62 | $56.89 | +21.8% | Jan 6, 2026 |
| Goldman Sachs | Richard Ramsden | $64 | $56.89 | +25.7% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $71 | $55.95 | +39.4% | Jan 5, 2026 |
| Truist Financial | Analyst unavailable | $58 | $54.8 | +13.9% | Dec 18, 2025 |
| Morgan Stanley | Analyst unavailable | $68 | $54.72 | +33.5% | Dec 12, 2025 |
| Piper Sandler | Analyst unavailable | $56 | $54.08 | +10.0% | Dec 11, 2025 |
| Wells Fargo | Analyst unavailable | $62 | $52.57 | +21.8% | Oct 27, 2025 |
| Piper Sandler | Analyst unavailable | $55 | $52.28 | +8.0% | Oct 16, 2025 |
| UBS | Analyst unavailable | $57 | $50.28 | +11.9% | Oct 7, 2025 |
| Goldman Sachs | Analyst unavailable | $55 | $52.42 | +8.0% | Sep 30, 2025 |
| Morgan Stanley | Analyst unavailable | $66 | $52.21 | +29.6% | Sep 29, 2025 |
| Truist Financial | John McDonald | $56 | $52.16 | +10.0% | Sep 24, 2025 |
| RBC Capital | Analyst unavailable | $53 | $47.32 | +4.1% | Jun 30, 2025 |
| Argus Research | Stephen Biggar | $47 | $37.33 | -7.7% | Apr 16, 2025 |
| Robert W. Baird | Analyst unavailable | $50 | $41.4 | -1.8% | Mar 7, 2025 |
| Morgan Stanley | Betsy Graseck | $54 | $46.08 | +6.0% | Jan 7, 2025 |
| Oppenheimer | Chris Kotowski | $54 | $44.31 | +6.0% | Jan 3, 2025 |
| Goldman Sachs | Richard Ramsden | $48 | $42.95 | -5.7% | Oct 16, 2024 |
| Oppenheimer | Chris Kotowski | $50 | $42.14 | -1.8% | Oct 16, 2024 |
| Evercore ISI | Glenn Schorr | $45 | $42.14 | -11.6% | Oct 16, 2024 |
| Piper Sandler | Scott Siefers | $44 | $40.4 | -13.6% | Sep 3, 2024 |
| Deutsche Bank | Matt O'Connor | $45 | $40.75 | -11.6% | Sep 3, 2024 |
| CFRA | Kenneth Leon | $39 | $36.92 | -23.4% | Aug 6, 2024 |
| RBC Capital | Gerard Cassidy | $46 | $44.13 | -9.7% | Jul 17, 2024 |
| Goldman Sachs | Richard Ramsden | $45 | $44.27 | -11.6% | Jul 16, 2024 |
| Wedbush | Jay McCanless | $144 | $41 | +182.8% | Jul 9, 2024 |
| Piper Sandler | Scott Siefers | $42 | $40.62 | -17.5% | Jul 9, 2024 |
| Evercore ISI | Glenn Schorr | $43 | $40.93 | -15.6% | Jul 3, 2024 |
| Jefferies | Analyst unavailable | $41 | $40.9 | -19.5% | Jul 3, 2024 |
| Seaport Global | Jim Mitchell | $48 | $40.18 | -5.7% | Jul 2, 2024 |
| Evercore ISI | Mark Mahaney | $75 | $39.34 | +47.3% | Jun 14, 2024 |
| Piper Sandler | Scott Siefers | $37 | $39.88 | -27.3% | Jun 4, 2024 |
| Wolfe Research | Steven Chubak | $42 | $35.77 | -17.5% | Apr 19, 2024 |
| RBC Capital | Gerard Cassidy | $39 | $35.23 | -23.4% | Apr 17, 2024 |
| Oppenheimer | Chris Kotowski | $45 | $35.6 | -11.6% | Apr 17, 2024 |
| BMO Capital | James Fotheringham | $37 | $34.68 | -27.3% | Apr 17, 2024 |
| Robert W. Baird | David George | $38 | $34.68 | -25.4% | Apr 17, 2024 |
| Wells Fargo | Mike Mayo | $44 | $37.62 | -13.6% | Mar 28, 2024 |
| HSBC | Saul Martinez | $39 | $37.81 | -23.4% | Mar 28, 2024 |
| Morgan Stanley | Betsy Graseck | $41 | $34.79 | -19.5% | Jan 30, 2024 |
| Loop Capital Markets | James Fotheringham | $36 | $32.12 | -29.3% | Jan 16, 2024 |
| BMO Capital | James Fotheringham | $40 | $33.15 | -21.4% | Jan 12, 2024 |
| Loop Capital Markets | James Fotheringham | $40 | $27.59 | -21.4% | Oct 18, 2023 |
| HSBC | Saul Martinez | $35 | $27.02 | -31.3% | Oct 16, 2023 |
| Oppenheimer | Chris Kotowski | $47 | $30.01 | -7.7% | Apr 19, 2023 |
| Oppenheimer | Analyst unavailable | $53 | $35.92 | +4.1% | Feb 2, 2023 |
| Barclays | Jason Goldberg | $48 | $34.47 | -5.7% | Jan 13, 2023 |
| Oppenheimer | Analyst unavailable | $51 | $32.77 | +0.2% | Dec 28, 2022 |
| Piper Sandler | Analyst unavailable | $36 | $32.74 | -29.3% | Dec 8, 2022 |
| Morgan Stanley | Analyst unavailable | $38 | $33.42 | -25.4% | Dec 6, 2022 |
| RBC Capital | Analyst unavailable | $40 | $33.21 | -21.4% | Jul 19, 2022 |
| Credit Suisse | Analyst unavailable | $43 | $32.26 | -15.6% | Jul 19, 2022 |
| Goldman Sachs | Richard Ramsden | $39 | $32.26 | -23.4% | Jul 18, 2022 |
| Piper Sandler | Jeffery Harte | $47 | $31.79 | -7.7% | Jul 10, 2022 |
| Credit Suisse | Analyst unavailable | $45 | $32.31 | -11.6% | Jun 27, 2022 |
| Morgan Stanley | Betsy Graseck | $47 | $32.31 | -7.7% | Jun 24, 2022 |
| Morgan Stanley | Analyst unavailable | $47 | $32.08 | -7.7% | Jun 24, 2022 |
| RBC Capital | Analyst unavailable | $45 | $32.02 | -11.6% | Jun 14, 2022 |
| Capital One Financial | Analyst unavailable | $46 | $39.5 | -9.7% | Apr 19, 2022 |
| BMO Capital | Analyst unavailable | $46 | $39.51 | -9.7% | Apr 19, 2022 |
| Citigroup | Keith Horowitz | $47 | $38.85 | -7.7% | Apr 19, 2022 |
| Jefferies | Ken Usdin | $43 | $37.57 | -15.6% | Apr 15, 2022 |
| Piper Sandler | Jeffery Harte | $51 | $39.67 | +0.2% | Apr 8, 2022 |
| Morgan Stanley | Betsy Graseck | $49 | $40.9 | -3.8% | Apr 2, 2022 |
| Robert W. Baird | David George | $42 | $38.59 | -17.5% | Mar 8, 2022 |
| Evercore ISI | Glenn Schorr | $52 | $45.53 | +2.1% | Jan 20, 2022 |
| Argus Research | Stephen Biggar | $55 | $45.53 | +8.0% | Jan 20, 2022 |
| Goldman Sachs | Richard Ramsden | $54 | $46.21 | +6.0% | Jan 19, 2022 |
| Piper Sandler | Jeffery Harte | $57 | $47.91 | +11.9% | Jan 16, 2022 |
| Citigroup | Keith Horowitz | $57 | $48.62 | +11.9% | Jan 12, 2022 |
| Wolfe Research | Steven Chubak | $49 | $47.76 | -3.8% | Jan 4, 2022 |
| Barclays | Jason Goldberg | $58 | $45.96 | +13.9% | Jan 3, 2022 |
| UBS | Erika Najarian | $64 | $44.27 | +25.7% | Dec 9, 2021 |
| Odeon Capital Group LLC | Richard Bove | $46.5 | $40.54 | -8.7% | Sep 13, 2021 |
| Credit Suisse | Susan Roth Katzke | $47 | $37.36 | -7.7% | Jul 16, 2021 |
| KBW | David Konrad | $40 | $39.48 | -21.4% | Jul 6, 2021 |
| Bank of America Securities | Gregg Gilbert | $48 | $42.13 | -5.7% | Jun 2, 2021 |
Track every rating change on BAC the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationOperating globally through its various subsidiaries, Bank of America Corporation offers a comprehensive range of banking and financial products and services. Its extensive clientele includes individual consumers, small and mid-market businesses, institutional investors, large corporations, and government bodies worldwide. The Consumer Banking division provides diverse options such as traditional and money market savings accounts, certificates of deposit, individual retirement accounts (IRAs), and both interest-bearing and non-interest-bearing checking accounts, in addition to investment products. This segment also issues credit and debit cards, originates residential mortgages and home equity loans, and offers direct and indirect financing for needs like automotive purchases, recreational vehicles, and personal loans. Within its Global Wealth & Investment Management segment, the company delivers investment management, brokerage, banking, and trust and retirement solutions.…
Historical context
All BAC earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| GL Globe Life Inc. | FY2026 Q3 · Calendar Q4 2026 | -1.2% | -3.8% | Globe Life: Premium Growth Holds as Health Margins Face Pressure |
| HBANL Huntington Bancshares Incorporated | FY2026 Q3 · Calendar Q4 2026 | — | +0.8% | Huntington maintains 2027 targets as fee businesses drive growth |
| NDAQ Nasdaq, Inc. | FY2026 Q3 · Calendar Q4 2026 | — | +6.9% | Nasdaq Q3 growth stays strong as AI and always-on markets advance |
| BCS Barclays PLC | FY2026 Q3 · Calendar Q4 2026 | — | -2.7% | Barclays: growth holds, but efficiency execution remains key |
| SEIC SEI Investments Company | FY2026 Q3 · Calendar Q4 2026 | +3.8% | +1.2% | SEI Posts Broad Q3 Growth as ETFs and Alternatives Expand |
| SF Stifel Financial Corp | FY2026 Q3 · Calendar Q4 2026 | +1.4% | -0.6% | Stifel posts record Q3 EPS as wealth management and lending lead |
Latest beats and misses
Who reports nextBeat on EPS
- CACIFY2027 Q1 · October 21, 2026+16.6% EPS-1.5% move
- WCNFY2026 Q3 · October 21, 2026+3.9% EPS+8.8% move
- KMIFY2026 Q3 · October 21, 2026+9.2% EPS+1.2% move
- TXNFY2026 Q3 · October 21, 2026+7.4% EPS+2.5% move
- SEICFY2026 Q3 · October 21, 2026+3.8% EPS+1.2% move
- CSXFY2026 Q3 · October 21, 2026+7.3% EPS+0.7% move
Get the BAC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-10-17T05:10:49.140638+00:00
- Polygon adjusted daily market bars · 2026-10-22T15:30:47.267064+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-22T15:30:47.264196+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-22. For educational purposes only; not investment advice.